Abstract
Administration mode matters for 5‐fluorouracil therapy: Physiologically based pharmacokinetic evidence for avoidance of myelotoxicity by continuous infusion but not intravenous bolus
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have